✦ LIBER ✦

Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein

✍ Scribed by van de Donk, N W C J; Kamphuis, M M J; van Dijk, M; Borst, H P E; Bloem, A C; Lokhorst, H M

Book ID: 110055324
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 245 KB
Volume: 17
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402768

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of apoptosis and chemosensitiz

Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment

✍ S Hopkins-Donaldson; R Cathomas; AP Simões-Wüst; S Kurtz; L Belyanskya; RA Stahe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 28 KB

## Abstract The original article to which this Erratum refers was published in International Journal of Cancer (2003) 106(2) 160–166

Induction of apoptosis and chemosensitiz

Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment

✍ Sally Hopkins-Donaldson; Richard Cathomas; A. Paula Simões-Wüst; Stefanie Kurtz; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB

## Abstract Our study was designed to investigate the role of the anti‐apoptotic proteins Bcl‐2 and Bcl‐xL in the chemoresistance of cells derived from malignant pleural mesothelioma. First, we determined the basal expression levels of Bcl‐2 and Bcl‐xL in mesothelioma cells and examined the effect

Trichostatin A sensitizes TRAIL-resistan

Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins

✍ Tamer E. Fandy; Rakesh K. Srivastava 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 318 KB

Enhanced chemosensitivity of drug-resist

Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing

✍ Yao Zhao; Chun-lin Zhang; Bing-fang Zeng; Xiao-san Wu; Tian-Tian Gao; Yoshino Od 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 755 KB

567 Antisense-mediated downregulation of

567 Antisense-mediated downregulation of BCL-2 and BCL-XL expression in lung cancer cell lines: Biologic implication and potential therapeutic benefit

✍ Zangemeister-Wittke, U.; Ziegler, A.; Luedke, G.H.; Stahel, R.A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Nur77 converts phenotype of Bcl-B, an an

Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma

✍ Luciano, F.; Krajewska, M.; Ortiz-Rubio, P.; Krajewski, S.; Zhai, D.; Faustin, B 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 321 KB